Mar 2026· medRxiv· Vol 14, pp. 594· 0 citations· 26 references
Medicine
TL;DR
It is suggested that current general-purpose LLMs can deliver accurate debunking of widely documented vaccine myths under realistic conditions, but that linguistic complexity and framing-sensitive style may limit accessibility.
Abstract
Large language models (LLMs) are increasingly used by the public to seek health information, yet their reliability in addressing common vaccine myths remains unclear. We conducted an exploratory multi-vendor evaluation of three LLMs (GPT-5, Gemini 2.5 Flash, Claude Sonnet 4) using officially curated vaccination myths from Germany's public health institution and two realistic user framings as prompts: a curious skeptic and a convinced believer. All model responses were independently evaluated by two blinded medical experts for misconception addressal (binary), scientific accuracy, and communication clarity (5-point Likert scales). Additionally, blinded marketing experts ranked models for lay communication clarity, and Flesch-Kincaid Reading Ease scores were computed for all outputs. Across all myths, prompts, and models (11 x 2 x 3 = 66 rating items), medical raters found 100% successful refutation of misinformation. Scientific accuracy and clarity ratings were high and tightly clustered (median 4.0-4.5), with no combined score below 3 and substantial inter-rater agreement. Marketing experts independently ranked Gemini 2.5 Flash and GPT-5 highest for lay clarity, with Claude Sonnet 4 consistently less favored. Readability analysis revealed generally low accessibility, particularly for the convinced believer framing and for Claude Sonnet 4 outputs. Our findings suggest that current general-purpose LLMs can deliver accurate debunking of widely documented vaccine myths under realistic conditions, but that linguistic complexity and framing-sensitive style may limit accessibility. Careful integration of LLMs into public health channels, alongside transparent sourcing and readability optimization, could enable these models to be used as scalable tools for debunking vaccine myths.
Although contemporary LLMs increasingly reflect medical consensus for CNS metastases, inconsistent reliability remains a concern, underscoring the need for caution in patient use.
Michael Fiorino, Mei Hainline, Tanay Poddar et al.· Neuro-Oncology Advances· 0 citations
Overall, advanced prompting markedly improved model performance, and top-tier LLMs demonstrated robust interpretive capability, while caution is needed for variables with complex clinical semantics such as blood pressure.
Jiwon You, Hangsik Shin· npj Digital Medicine· 0 citations
Mapping these boundaries allows AMS teams, particularly those understaffed or without on-site infectious diseases expertise, to decide where LLM support adds value rather than risk, and endorsed LLMs as useful AMS support tools with moderate supervision.
Ángela Abejez-Arrizabalaga, Galadriel Pellejero-Sagastizabal, Rocío Aznar-Gimeno et al.· Clinical Microbiology and In...· 0 citations
On complex ID scenarios, large language models responses were variable and caution is required when deploying these models in ID domains without specialist oversight, suggesting caution is required when deploying these models in ID domains without specialist oversight.
A. Pradhan, B. Waxse, W. Matias et al.· medRxiv· 0 citations
Findings show that clinical LLM explainability has shifted toward fluent generative rationales, but evidence that such explanations reflect model reasoning remains limited, and three regulatory priorities are highlighted: prioritizing explanations that enable independent verification or logic auditing over plausibility-only rationales; preferring inspectable models where regulatory documentation is required; and prospectively validating explanations in clinical workflows before scaling.